Allarity Therapeutics, Inc.(NASDAQ:ALLR) 
Allarity Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing oncology therapeutics using drug-specific companion diagnostics generated by its drug response predictor technology. Its drug candidates include Stenoparib, a poly-ADP-ribose polymerase inhibitor that is i...
Website: https://www.allarity.com
Founded: 2004
Full Time Employees: 13
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 0.77
H 0.82
L 0.75
C 0.79
V 1,145,533
10EMA 0.79
20EMA 0.79
60EMA 0.79
120EMA 0.79
250EMA 0.79